General Electric's turbine business in Schenectady got a giant boost from $2.7 billion of contracts for electric generators, as well as gas and steam turbines headed to Algeria. The company has already hired some workers in anticipation of the contract. Hiring also continues at the company's battery plant, also in Schenectady.
General Electric's digital x-ray imaging equipment manufacturing plant in Rensselaer County is adding machinery and hiring up to 25 new workers. The company is expanding into new areas of use for the technology.
Apprenda, a software developer in Clifton Park (Saratoga County), has signed several new customers from the New York City area. The company will expand its office space by the end of October and begin looking for about 30 new employees with strong computer science and math skills.
Bow Tie Cinemas, the eighth largest theater circuit in the nation, will be opening two new movie houses in Saratoga County in October. The first will be in Downtown Saratoga Springs with the second opening a week later at the nearby Wilton Mall. These high-end theaters include beer and wine bars and a hot-food and pastry concession in the lobby. The company currently operates one facility in downtown Schenectady.
General Electric will be eliminating between 100 and 200 local jobs at its global Power and Water business, headquartered in Schenectady. The cutbacks will occur in administrative activities, as production workers are not impacted. Many of these workers may find reemployment opporunities within the company.
General Electric announced plans to move electrical capacitor production from Fort Edward (Washington County) to Florida, eliminating nearly 200 local jobs. The proposed closure is subject to a 60-day decision bargaining period with the union. If there is no change in plans during this period, the plant could close by September 2014.
Delcath Systems Inc., a Warren County pharmaceutical and medical device company, will be eliminating between 10 and 20 local jobs in October. This follows a similar cutback in June. The company has been trying to get approval to sell its liver chemotherapy system in the United States for several years, but last month the Food and Drug Administration informed them that additional tests are needed.
Thanks for the feedback! It will help us improve your experience.